Results for tag: "D4 Agonist"

The D4 Agonist market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. D4 Agonists are a type of drug that act on the dopamine D4 receptor, which is involved in the regulation of emotions, cognition, and behavior. These drugs are used to treat a variety of conditions, including schizophrenia, bipolar disorder, and attention deficit hyperactivity disorder (ADHD). D4 Agonists are typically administered orally, and are often used in combination with other drugs to maximize their effectiveness. Common side effects of these drugs include drowsiness, dizziness, and nausea. As with any drug, it is important to consult a doctor before taking a D4 Agonist. Some companies in the D4 Agonist market include Eli Lilly, Pfizer, and Merck. These companies produce a variety of D4 Agonists, including aripiprazole, risperidone, and quetiapine. Show Less Read more